News from NIAID-Supported Institutions
National Institute of Allergy and Infectious Diseases sent this bulletin at 09/19/2014 10:49 AM EDT
Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases |
    Visit us on the Web |
Here’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:
Point-of-Care CD4 Testing is Economically Feasible for HIV Care in Resource-Limited Areas
September 16, 2014—Massachusetts General Hospital
September 16, 2014—Massachusetts General Hospital
ContraFect Corporation's Universal Influenza Treatment Receives SBIR Funding
September 16, 2014—ContraFect Corporation
Professor Dennis Burton: In Search of an Effective HIV/AIDS Vaccine
September 15, 2014—The Scripps Research Institute
New Insights in Survival Strategies of Bacteria
September 14, 2014—VIB (the Flanders Institute for Biotechnology)
September 14, 2014—VIB (the Flanders Institute for Biotechnology)
Geneva & Partners in Development of Ebola Drug
September 12, 2014—The Geneva Foundation
September 12, 2014—The Geneva Foundation
Intestinal Bacteria Needed for Strong Flu Vaccine Responses in Mice
September 11, 2014—Emory University
September 11, 2014—Emory University
PharmAthene Awarded Contract of Up to $28.1 Million to Develop Next Generation Thermostable Anthrax Vaccine
September 10, 2014—PharmAthene, Inc.
September 10, 2014—PharmAthene, Inc.
Study Sheds Light on Asthma and Respiratory Viruses
September 9, 2014—Washington University School of Medicine in St. Louis
September 9, 2014—Washington University School of Medicine in St. Louis
Unusual Immune Cell Needed to Prevent Oral Thrush, Pitt Researchers Find
September 8, 2014—University of Pittsburgh School of Medicine
September 8, 2014—University of Pittsburgh School of Medicine
Suppressing Food Allergies Quickly Is the Goal of UC Research Team
September 8, 2014—University of Cincinnati College of Medicine
September 8, 2014—University of Cincinnati College of Medicine
Emergent BioSolutions Awarded Contract to Develop a Dry Formulation of NuThrax, a Next Generation Anthrax Vaccine
September 8, 2014—Emergent BioSolutions Inc.
Team Identifies Important Regulators of Immune Cell Response
September 8, 2014—The Scripps Research Institute
September 8, 2014—The Scripps Research Institute
MCW Scientists to Investigate New Therapy for Obstructive Lung Disease
September 4, 2014—The Medical College of Wisconsin
September 4, 2014—The Medical College of Wisconsin
Avian Influenza Virus Isolated in Harbor Seals Poses a Threat to Humans
September 4, 2014—St. Jude Children’s Research Hospital
Johnson & Johnson Responds to Ebola Crisis with Commitment to Accelerate Vaccine Program in Collaboration with the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid
September 4, 2014—Johnson & Johnson
September 4, 2014—Johnson & Johnson
Bavarian Nordic Accelerates Ebola Vaccine Development Programs in Collaboration with the U.S. National Institutes of Health
September 4, 2014—Bavarian Nordic
Leaky Gut—A Source of Non-AIDS Complications in HIV-Positive Patients
September 3, 2014—Case Western Reserve University School of Medicine
September 3, 2014—Case Western Reserve University School of Medicine
Soligenix Announces Positive Survival Results with Heat Stable Ricin Toxin Vaccine
September 2, 2014—Soligenix, Inc.
September 2, 2014—Soligenix, Inc.
Biochemists Find New Treatment Options for Staph Infections, Inflammatory Diseases
September 2, 2014—Kansas State University
These news releases were issued by organizations supported by NIAID. To receive NIAID-issued news releases, update your subscription preferences by selecting “News Releases.”
If you would like to see your NIAID-supported research featured here, contact us at niaidnews@niaid.nih.gov.
